Maiji Biotechnology
Shanghai
About Maiji Biotechnology
Maiji Bio is the first local company to create and test novel antibodies independently. It is dedicated to discovering new targets and compounds and the structural modification, design, and development of dual-function targeted pharmaceuticals based on independently produced innovative molecules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $27.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2024)
- Website: mabge.comen
Industries & Categories
Medical, Pharmaceutical
Canonical: https://fsome.com/organization/maiji-biotechnology-124428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.